Evaluation of Safety and Efficacy of ProHance in Pediatric Patients <2yrs

NCT03750188 · clinicaltrials.gov ↗

COMPLETED

Status

125

Enrollment

INDUSTRY

Sponsor class

Conditions

Central Nervous System Diseases
Central Nervous System Neoplasms

Interventions

DRUG: ProHance

Sponsor

Bracco Diagnostics, Inc